A Pseudomonas aeruginosa TIR effector mediates immune evasion by targeting UBAP1 and TLR adaptors

Biochemistry & Molecular Biology Virulence Factors INNATE BINDING PROTEIN DOMAIN-CONTAINING PROTEINS Cell Line 03 medical and health sciences Bacterial Proteins Pseudomonas Receptors Humans Immune Evasion TLR adaptors 08 Information And Computing Sciences 0303 health sciences Science & Technology CYSTIC-FIBROSIS Membrane Glycoproteins Virulence TIR domain BRUCELLA-MELITENSIS Toll-Like Receptors ESCRT-I COMPLEX Receptors, Interleukin-1 Epithelial Cells Cell Biology 11 Medical And Health Sciences Articles 06 Biological Sciences virulence ESCHERICHIA-COLI UBAP1 Myeloid Differentiation Factor 88 Pseudomonas aeruginosa SECRETION Carrier Proteins Life Sciences & Biomedicine RECEPTOR SIGNAL-TRANSDUCTION TOLL Interleukin-1 Developmental Biology
DOI: 10.15252/embj.201695343 Publication Date: 2017-05-09T00:10:41Z
ABSTRACT
AbstractBacterial pathogens often subvert the innate immune system to establish a successful infection. The direct inhibition of downstream components of innate immune pathways is particularly well documented but how bacteria interfere with receptor proximal events is far less well understood. Here, we describe a Toll/interleukin 1 receptor (TIR) domain‐containing protein (PumA) of the multi‐drug resistant Pseudomonas aeruginosa PA7 strain. We found that PumA is essential for virulence and inhibits NF‐κB, a property transferable to non‐PumA strain PA14, suggesting no additional factors are needed for PumA function. The TIR domain is able to interact with the Toll‐like receptor (TLR) adaptors TIRAP and MyD88, as well as the ubiquitin‐associated protein 1 (UBAP1), a component of the endosomal‐sorting complex required for transport I (ESCRT‐I). These interactions are not spatially exclusive as we show UBAP1 can associate with MyD88, enhancing its plasma membrane localization. Combined targeting of UBAP1 and TLR adaptors by PumA impedes both cytokine and TLR receptor signalling, highlighting a novel strategy for innate immune evasion.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (57)
CITATIONS (36)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....